Multi-center and Multi-modal Deep Learning Study of Gastric Cancer
- Conditions
- Stomach Neoplasms
- Interventions
- Radiation: The whole abdomen contrast-enhanced CT scanOther: H&E stained sections and slides
- Registration Number
- NCT05001321
- Lead Sponsor
- First Hospital of China Medical University
- Brief Summary
To assist postoperative pathological diagnosis and classification of gastric cancer by machine learning; To improve the accuracy of pathological diagnosis of gastric cancer by machine learning; To predict the effectiveness of treatment for gastric cancer by deep learning; To construct a model to predict the survival of gastric cancer patients by multimodal deep learning.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 3300
- The diagnosis of gastric cancer was confirmed by pathology;
- Preoperative enhanced abdominal CT;
- Available detailed clinical and pathological data;
- Integrated follow-up data.
- The patients had severe underlying disease;
- Overall survival was less than 3 months;
- No detailed information could be collected.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Training Group The whole abdomen contrast-enhanced CT scan Based on the inclusion criteria, 2000 gastric cancer patients will be recruited in the analysis. And a model will be constructed based on deep learning. Internal Validation Group H&E stained sections and slides Based on the inclusion criteria, 1000 gastric cancer patients will be recruited in this group to verify the sensitivity and specificity of the constructed model. External Validation Group H&E stained sections and slides Based on the inclusion criteria, 300 gastric cancer patients from 5 other medical centers will be recruited in this group to verify the sensitivity and specificity of the constructed model. Training Group H&E stained sections and slides Based on the inclusion criteria, 2000 gastric cancer patients will be recruited in the analysis. And a model will be constructed based on deep learning. Internal Validation Group The whole abdomen contrast-enhanced CT scan Based on the inclusion criteria, 1000 gastric cancer patients will be recruited in this group to verify the sensitivity and specificity of the constructed model. External Validation Group The whole abdomen contrast-enhanced CT scan Based on the inclusion criteria, 300 gastric cancer patients from 5 other medical centers will be recruited in this group to verify the sensitivity and specificity of the constructed model.
- Primary Outcome Measures
Name Time Method Growth pattern 1 day To assess the growth pattern on preoperative enhanced abdominal CT of patients with gastric cancer, including endophytic, exophytic and mixed.
Nucleus shape 1 day To obtain the nucleus shape of postoperative H\&E stained sections and slides of gastric cancer by deep learning.
Enhancement pattern 1 day To assess the enhancement pattern on preoperative enhanced abdominal CT of patients with gastric cancer, including homogeneous and heterogeneous.
Maximum diameter of tumor 1 day To measure the maximum diameter of tumor on preoperative enhanced abdominal CT of patients with gastric cancer.
Enhancement degree 1 day To assess the enhancement degree on preoperative enhanced abdominal CT of patients with gastric cancer, including hypoenhancement, isoenhancement and hyperenhancement.
Nucleus size 1 day To obtain the nucleus size of postoperative H\&E stained sections and slides of gastric cancer by deep learning.
Distribution of pixel intensity 1 day To obtain the distribution of pixel intensity of postoperative H\&E stained sections and slides of gastric cancer by deep learning.
Texture of nuclei 1 day To obtain the texture of nuclei of postoperative H\&E stained sections and slides of gastric cancer by deep learning.
- Secondary Outcome Measures
Name Time Method Survival status 1 day To analyze the survival status of patients with gastric cancer, involving dead and alive.
Recurrence/metastasis 1 day To calculate the days to recurrence/metastasis of patients with gastric cancer.
Overall survival 1 day To calculate the overall survival of patients with gastric cancer based on days to death and days to last follow-up.
Trial Locations
- Locations (6)
The fourth People's Hospital of Changzhou
🇨🇳Changzhou, Jiangsu, China
Chaoyang Central Hospital
🇨🇳Chaoyang, Liaoning, China
The General Hospital of Fushun Mining Bureau
🇨🇳Fushun, Liaoning, China
First Hospital of Jinzhou Medical University
🇨🇳Jinzhou, Liaoning, China
The First Affiliated Hospital of China Medical University
🇨🇳Shenyang, Liaoning, China
The Second Hospital of Shandong University
🇨🇳Ji'nan, Shandong, China